Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Mantle Cell Lymphoma

Breast Cancer

Gastrointestinal Cancer

Mantle Cell Lymphoma

Acalabrutinib Regimen Highly Active in MCL

Adding the BTK inhibitor acalabrutinib to bendamustine and rituximab induced high overall response rates in both treatment-naive and relapsed/refractory patients with mantle cell lymphoma.
Read More >>

ASH 2018: Acalabrutinib Monotherapy Produces Durable Response in Mantle Cell Lymphoma

ASH 2018: Zanubrutinib Highly Active in Relapsed/Refractory MCL

Cohen Discusses Future of MCL Treatment

Expert Explains Treatment Approaches for MCL

Future of MCL Treatment May Lie in Combinations, CAR T-Cell Therapy

View More Stories >>

View Conference Coverage

2018 San Antonio Breast Cancer Symposium

2018 ASH Annual Meeting

2018 Ruesch Center Symposium

2018 Chemotherapy Foundation Symposium

2018 New York Lung Cancers Symposium

Dr. Rule on Treatment of Young, Fit Patients With MCL

Dr. Dean Discusses Ongoing Research on Biomarkers in MCL

Dr. Cohen Discusses CAR T-Cell Therapy in MCL

Dr. Wang Discusses New Agents in the Field of MCL

Dr. Shah on Challenges in Treating Patients With High-Risk MCL

Dr. Rule Addresses Questions on the Watch-and-Wait Approach in MCL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Highlights from ASH 2017: Mantle Cell Lymphoma

Investigational Treatment in Mantle Cell Lymphoma

Future Therapy: Bruton's TKI Containing Combinations in MCL

Allogeneic Transplantation in Mantle Cell Lymphoma

Acalabrutinib in Relapsed Mantle Cell Lymphoma

Ibrutinib in Relapsed Mantle Cell Lymphoma

Understanding Relapse in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

How to Properly Utilize MRD Testing

Emerging Agents for Mantle Cell Lymphoma

Acalabrutinib for Treating Mantle Cell Lymphoma

Ongoing Challenges in Treating Mantle Cell Lymphoma

$Treating Relapsed/Refractory Mantle Cell Lymphoma$

Role of Maintenance Therapy in Mantle Cell Lymphoma

Response Assessment in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Ibrutinib in Relapsed Mantle Cell Lymphoma

Drs Danilov, Goy, Leonard, Pagel, and Schuster, discuss ibrutinib (Imbruvica) as a treatment in relapsed mantle cell lymphoma. View Now

Treatments for Relapsed Mantle Cell Lymphoma

Brad S. Kahl, MD, and Richard R. Furman, MD, explain available treatment options for relapsed mantle cell lymphoma. View Now

Featured Video

Novel Combination Approaches for Metastatic Kidney Cancer

Brian Rini, MD, and David F. McDermott, MD, discuss novel combination approaches for patients with metastatic renal cell carcinoma. View now

FDA Approvals in NTRK-Fusion Cancers, AML, and SAA, and Priority Review in AML

Gina Columbus highlights the latest news in oncology in this week's OncLive News Network.

OncLive News Network On Location: In San Diego Monday, December 3

Trending Now

Despite Success With Targeted Therapies in NSCLC, Drug Resistance Remains Issue

Novel Antibody-Drug Conjugate Enters Phase III Trial for Metastatic TNBC

Progress and Challenges Mark the Myelofibrosis Landscape

Focal Therapy Evolves Into More Precise Treatment in Prostate Cancer

Publications

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions